Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
24.77
+0.67 (2.78%)
Aug 11, 2026, 4:00 PM EDT - Market closed
Aktis Oncology Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 14, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $30 → $33 | Buy | Reiterates | $30 → $33 | +33.23% | Jul 14, 2026 |
| Raymond James | Raymond James | Buy Initiates $40 | Buy | Initiates | $40 | +61.49% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $35 | Buy | Reiterates | $35 | +41.30% | Jun 2, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $34 | Buy | Maintains | $34 | +37.26% | Jun 1, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 11, 2026 |